Data / Form D filings / Kailos Genetics, Inc.
Kailos Genetics, Inc.: Form D filings
Kailos Genetics, Inc., a biotechnology company in Huntsville, AL, filed 7 Form D notices with the SEC between 2010 and 2018. The latest, on April 17, 2018, reports $2 million sold of a $2 million offering to 8 investors.
Find out what Kailos Genetics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 601 GENOME WAY, Huntsville, AL, 35806
- Phone
- (256) 327-9800
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1503871
The full lists. Form D filings in Alabama: 291 rows, $14.55, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 17, 2018 | New notice | $2,000,000 | $1,975,000 | $25,000 | 8 | Feb 28, 2018 | sec.gov |
| Nov 16, 2016 | New notice | $2,000,000 | $0 | $2,000,000 | 0 | Yet to occur | sec.gov |
| Aug 26, 2015 | New notice | $4,000,000 | $0 | $4,000,000 | 0 | Yet to occur | sec.gov |
| Jul 1, 2014 | New notice | $2,500,000 | $0 | $2,500,000 | 0 | Yet to occur | sec.gov |
| May 1, 2013 | New notice | $4,000,000 | $0 | $4,000,000 | 0 | Yet to occur | sec.gov |
| Dec 20, 2011 | New notice | $4,000,000 | $1,900,000 | $2,100,000 | 4 | Dec 5, 2011 | sec.gov |
| Oct 21, 2010 | New notice | $3,500,000 | $0 | $3,500,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael J. Walters | Director | |
| Danny R. Windham | Director | |
| David Troy Moore | Executive Officer, Director | |
| Brian K. Pollock | Executive Officer, Director | |
| Randall C. Bachmeyer | Executive Officer | |
| Cheri R. Walker | Executive Officer | |
| James R. Hudson, Jr. | Director | |
| Katherine T. Varley | Director |
Other biotechnology companies in Alabama that filed recently
- Khaya Biosciences, Inc. $200,000 · Aug 13, 2026
Every Form D from the week of Apr 16, 2018 · All recent filings in Alabama · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Kailos Genetics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.